Lenvatinib
Product Specifications
CAS Number
417716-92-8
Target
C-RET, VEGFR, FGFR, PDGFR, c-Kit
Related Pathways
Tyrosine Kinase/Adaptors, Apoptosis, Angiogenesis
Purity
0.9996
Bioactivity
Lenvatinib (E7080) is a multi-target receptor tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, KIT, PDGFR, and RET, and has oral activity. Lenvatinib has the strongest inhibitory activity on VEGFR2 and VEGFR3 (IC50=4/5.2 nM) . Lenvatinib has strong anti-tumor activity.
Smiles
O(C=1C2=C(C=C(OC)C(C(N)=O)=C2)N=CC1)C3=CC(Cl)=C(NC(NC4CC4)=O)C=C3
Molecular Formula
C21H19ClN4O4
Molecular Weight
426.85
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
034425-APC 200 µL
CYP21A2, ID (CYP21A2, CYP21, CYP21B, Steroid 21-hydroxylase, 21-OHase, Cytochrome P-450c21, Cytochrome P450 21, Cytochrome P450 XXI, Cytochrome P450-C21, Cytochrome P450-C21B) (APC) discontinued
Sign In for Pricing
View Details 
